Susannah Gray's Net Worth
$221 Thousand
Who is Susannah Gray?
Susannah Gray does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Apria, Inc., Morphic Holding, Inc., 4D Molecular Therapeutics, Inc., MARAVAI LIFESCIENCES HOLDINGS, INC., and Theravance Biopharma, Inc..
SEC CIK
Susannah Gray's CIK is 0001833453
Past Insider Trading and Trends
2023 was Susannah Gray's most active year for acquiring shares with 9 total transactions. Susannah Gray's most active month to acquire stocks was the month of April. 2024 was Susannah Gray's most active year for disposing of shares, totalling 4 transactions. Susannah Gray's most active month to dispose stocks was the month of July. 2020 saw Susannah Gray paying a total of $540,000.00 for 31,852 shares, this is the most they've acquired in one year. In 2022 Susannah Gray cashed out on 5,059 shares for a total of $189,712.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Apria, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Morphic Holding, Inc. (MORF) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
4D Molecular Therapeutics, Inc. (FDMT) Snapshot price: $15.07
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) Snapshot price: $9.05
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +34.34% | 20.64K |
$10.78 | $222,553.10 | 80.77K |
May 23
| |||
Form 4
| +66.44% | 24K |
—
|
—
| 60.12K |
Jul 17
| |||
Form 4
| +13.41% | 4.27K |
—
|
—
| 36.12K |
Nov 19
| |||
Form 4
| +168.75% | 20K |
$27.00 | $540,000.00 | 31.85K |
Nov 24
| |||
Form 4
|
∞
| 11.85K |
—
|
—
| 11.85K |
Nov 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Theravance Biopharma, Inc. (TBPH) Snapshot price: $8.01
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +50.29% | 10.54K |
—
|
—
| 31.49K |
May 8
| |||
Form 4
| +77.27% | 9.13K |
—
|
—
| 20.95K |
May 2
| |||
Form 4
|
∞
| 11.82K |
—
|
—
| 11.82K |
Feb 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |